Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle
NCT04558190Completed
- Sponsor
- University of Copenhagen
- Start
- Sep 2020
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Trial of mitoquinone and salbutamol in insulin resistance (IR) (4 arms), sponsored by University of Copenhagen. Primary endpoints: Whole body Insulin sensitivity at 5 hours and Skeletal muscle insulin sensitivity at 5 hours. Started Sep 2020; status: completed.
02
Drugs
mitoquinonesalbutamol
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT04558190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04558190.